New to Meducation?
Sign up
Already signed up?
Log In
Add To Boards
Add
Upvote
0
CPD Tracker
00:00
Aprepitant Decreases Cough in Patients With Lung Cancer
First antitussive trial in lung cancer patients identifies promising treatment for bothersome cough.
#Respiratory
x
#Oncology
x
#PulmonaryMedicine
x
#MedicalOncology
x
#LungNeoplasms
x
Help by adding tags...
Lung Cancer | Doctor | Patient
- The management guidelines for small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC) in this article are taken from the guidelines published...
1
19
Trending
Cranial Nerves - Anatomy, Clinical Signs and Study Tips
- This is a teaching resource that aids the student in memorisation of the Cranial Nerves, their anatomical path and function. Additionally, it stimulates a clinical approach to the functions of t...
1186
40270
One in four advanced lung cancer patients tested for EGFR mutations started on first-line treatment before test results available
- Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European...
0
2
Dual therapy's 1-2 punch knocks out drug-resistant lung cancer
- Unusual chance to study patient's residual tumor leads to new findingCapitalizing on a rare opportunity to thoroughly analyze a tumor from a lung cancer patient who had...
0
19
EGFR Testing Not Done in 25% of Lung Cancer Patients
- Not all patients with advanced NSCLC undergo testing for the EGFR mutation, and for some patients who do undergo testing, therapy is initiated before the results are received.
0
14
